Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Recruitment

Liftstream is an executive search recruitment company in the life sciences sector

Clarus Ventures Strengthens Investment Team with 3 Hires

Clarus Ventures, a life sciences investment firm, has appointed Kiran Reddy and Robert DeBenedetto to Venture Partner, and Lazar Dimitrov to Associate. Based in the firm’s Cambridge, Mass. office, Reddy will focus on both new company formation and risk-sharing partnerships … Continue reading

Posted in Executive Appointments | Tagged , , , , , , , , , , , , | Leave a comment

Third Rock Ventures Recruits Industry Heavyweight Michael Bonney

Boston based venture capital powerhouse Third Rock Ventures, have announced the appointment of Michael W. Bonney as partner. Mr. Bonney was previously the CEO of Cubist Pharmaceuticals until its acquisition by Merck & Co. Mr. Bonney brings to Third Rock … Continue reading

Posted in Executive Appointments | Tagged , , , , , , , , , , | Leave a comment

Scott Morrison Nets Two Board Appointments

Scott Morrison, a retired Ernst & Young Partner, was appointed to the board of directors at Audentes Therapeutics and Global Blood Therapeutics.Watch Full Movie Online Streaming Online and Download Audentes Therapeutics is a San Francisco-based biotechnology company committed to the … Continue reading

Posted in Board Director Appointments | Tagged , , , , , , , , , , | Leave a comment

$40m for rare focused Rhythm

Rhythm announced today the completion of a $40 million Series A financing for its subsidiary, Rhythm Metabolic, Inc., which is developing setmelanotide (RM-493), a novel peptide MC4 agonist for the treatment of obesity caused by genetic deficiencies in the MC4 … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , | Leave a comment

Editas adds CFO and $120m in Series B round

Editas Medicine, a leading genome editing company, today announced that it has raised $120 million in a highly oversubscribed Series B private financing. The financing assembles a broad syndicate of leading public and private investors who underpin many of the … Continue reading

Posted in Executive Appointments, M&A Finance and Funding | Tagged , , , , , , , , , , , , , , | Leave a comment

Executive and Board Director Appointments in Oncology and Rare Diseases

Third Rock Ventures portfolio company, Voyager Therapeutics, a gene therapy player in the field of CNS based out of Cambridge, Mass. have appointed Michael Higgins to the Board of Directors. Mr. Higgins is an experienced biotechnology executive and is currently an … Continue reading

Posted in Executive Appointments | Tagged , , , , , , , , , , , , , , , , | Leave a comment

What does it take to reach and succeed at the ‘C’ and Board level?

Liftstream has been collaborating with two organisations to put together a key leadership meeting on gender diversity in biotechnology. The event is based on our published research and we have worked with our network of executives to bring about an … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Third Rock Ventures shows promise with early stage investment strategy

Authored by Karl Simpson – April 2013 When the biotechnology industry’s great and good assemble in Chicago for BIO this week, few there will have had such an illustrious beginning to the year as Mark Levin’s Boston based Third Rock Ventures. … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , | Leave a comment

Executive Recruitment Roundup – July

Authored by Liftstream Since ViroPharma Inc was acquired by Shire, many of the company’s leadership have moved to other parts of the sector and the VP Global Regulatory Affairs, Robert Pietrusko is no exception. He has just joined the Cambridge, … Continue reading

Posted in Executive Appointments, Recruitment Market | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Executive Recruitment Roundup – Biotechnology – June 2014

Authored by Karl Simpson Annalisa Jenkins joins the Board of Biothera, the immuno-oncology company. Dr. Jenkins, until recently the Global Head of R&D at Merck Serono and presently the Chairman or TransCelerate. Biothera’s product, Imprime PGG, is a novel cancer … Continue reading

Posted in Executive Appointments, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap